(1.南华大学附属第一医院心内科,,湖南省衡阳市 421001;2.南华大学心血管疾病研究所,,湖南省衡阳市 421001;3.湖南省心肌损伤临床医学研究中心,,湖南省衡阳市 421001 ;4.南华大学附属第一医院心血管疾病研究所,湖南省衡阳市 421001)
贺喆,硕士研究生,研究方向为动脉粥样硬化病因发病学与防治基础,E-mail为1012844224@qq.com。通信作者唐惠芳,教授,主任医师,硕士研究生导师,研究方向为心力衰竭和心律失常的发病机制,E-mail为tanghuifang999@163.com。
湖南省技术创新引导计划-临床医疗技术创新引导项目(2018SK51603);湖南省卫健委项目(B2019122);湖南省卫健委重点指导课题(20201920);湖南省科技创新重点工程项目(2020SK1013-2);湖南创新型省份建设专项经费(2020SK4008);衡阳市科技局新冠肺炎防治基础研究专项项目(202010031573);南华大学新冠肺炎疫情防控应急专项项目(2020-17)
HE Zhe
Department of Cardiology, the First Affiliated Hospital, University of South China, Hengyang, Hunan 421001, China;Institute of Cardiovascular Diseases, University of South China, Hengyang, Hunan 421001, China;Clinical Research Center for Myocardial Injury in Hunan Province, Hengyang, Hunan 421001, China;Institute of Cardiovascular Diseases, the First Affiliated Hospital, University of South China, Hengyang, Hunan 421001, ChinaTANG Huifang
Department of Cardiology, the First Affiliated Hospital, University of South China, Hengyang, Hunan 421001, China;Clinical Research Center for Myocardial Injury in Hunan Province, Hengyang, Hunan 421001, China;Institute of Cardiovascular Diseases, the First Affiliated Hospital, University of South China, Hengyang, Hunan 421001, China1.Department of Cardiology, the First Affiliated Hospital, University of South China, Hengyang, Hunan 421001, China;2.Institute of Cardiovascular Diseases, University of South China, Hengyang, Hunan 421001, China;3.Clinical Research Center for Myocardial Injury in Hunan Province, Hengyang, Hunan 421001, China;4.Institute of Cardiovascular Diseases, the First Affiliated Hospital, University of South China, Hengyang, Hunan 421001, China)
贺喆,危当恒,唐惠芳.琥珀酸与代谢性疾病的研究进展[J].中国动脉硬化杂志,2022,30(5):454~460.
复制